AzTrials
AzTrials

Endoscopic Retrograde CholangiopancreatographyNCT02297750

Optimal Timing of Double-Wire Technique For Biliary Cannulation at ERCP

A study testing double-wire technique in patients undergoing ERCP with biliary cannulation and single-wire technique in patients undergoing ERCP with biliary cannulation in people with Endoscopic Retrograde Cholangiopancreatography, run by Duke University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to give doctors who perform Endoscopic Retrograde Cholangiopancreatography (ERCP) procedures a better idea as to the best techniques to use in order to examine the bile duct as quickly and safely as possible. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
double-wire technique in patients undergoing ERCP with biliary cannulation and single-wire technique in patients undergoing ERCP with biliary cannulation
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
161 participants
Where
1 siteUnited States
Study dates
Aug 2012to Jun 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients undergoing ERCP with primary intent to cannulate the bile duct
  • Written informed consent

Who cannot join

  • Age < 18 years
  • Non-naive papilla (previous sphincterotomy)
  • Surgically altered anatomy
  • Known/suspected pancreas divisum
  • Suspected SOD/biliary manometry
  • Prior ERCP/stent within 3 months
  • ERCP performed in the Operating Room or at Duke North
  • Pregnancy/breast-feeding

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Duke University Medical Center

    Durham, North Carolina, 27710

Other trials in United States

About this study

The purpose of this study is to give doctors who perform Endoscopic Retrograde Cholangiopancreatography (ERCP) procedures a better idea as to the best techniques to use in order to examine the bile duct as quickly and safely as possible.

Read the detailed description

Sometimes, in the course of a regular ERCP procedure, techniques used by the doctor to pass a wire into the bile duct can result in the pancreas duct being entered instead. When this happens, the doctor may either remove the wire (known as "single wire" technique) or leave it in and use a second wire ("double wire") to enter the bile duct. This study will try to determine whether the "double wire" technique or the "single wire" technique removing the wire is the safest and most efficient.

Being tested
double-wire technique in patients undergoing ERCP with biliary cannulation, single-wire technique in patients undergoing ERCP with biliary cannulation
Keywords
The focus of the study is double-wire technique versus single wire technique in patients undergoing ERCP with biliary cannulation as the primary objective.

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • double-wire technique in patients undergoing ERCP with biliary cannulationProcedure or surgery

  • single-wire technique in patients undergoing ERCP with biliary cannulationProcedure or surgery

Study groups in NCT02297750
Study groupRoleWhat they receive
single wire techniqueActive comparatorsingle wire technique in patients undergoing ERCP with biliary cannulation
Receives: Procedure: single-wire technique in patients undergoing ERCP with biliary cannulation
Double wire techniqueActive comparatordouble-wire technique in patients undergoing ERCP with biliary cannulation
Receives: Procedure: double-wire technique in patients undergoing ERCP with biliary cannulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Success of biliary cannulation

    The primary outcome is incidence of successful deep biliary cannulation within 10 minutes.

    Measured: 10 minutes after randomization

Secondary outcomes (3)
  1. Success of biliary cannulation

    Number of attempts required for successful biliary cannulation

    Measured: 2 days after the procedure

  2. Time to successful biliary cannulation

    Measured: 2 days after the procedure

  3. Post-ERCP pancreatitis

    Measured: 2 days after the procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Nov 2014 (estimated)
  2. Study startAug 2012
  3. Primary completionJun 2015
  4. Study completionJun 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
161 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02297750
Sponsor's protocol ID
Pro00033706
Status last verified
Nov 2014
First submitted
19 Nov 2014
Last updated
26 Oct 2015
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing double-wire technique in patients undergoing ERCP with biliary cannulation and single-wire technique in patients undergoing ERCP with biliary cannulation in people with Endoscopic Retrograde Cholangiopancreatography, run by Duke University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Oct 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Success of biliary cannulation (time frame: 10 minutes after randomization). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Oct 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in